Search

everythinglearnresearchcommunity

for

Search:↓

FER and TOR signaling help root hair growth in low temperature and low nitrate conditions.

Hairless rats are good for testing anti-inflammatory drugs, similar to haired rats, without needing to remove fur.

RNase L hinders hair growth by altering immune signals.

A patient with hair loss condition grew excessive hair in areas covered by a cast.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Non-coding RNAs play key roles in the hair growth cycle of Angora rabbits.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

The study provides exploratory findings on miRNA changes in female hair loss.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

RNase L suppresses regeneration in mammals.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Mutations in specific llama genes may affect fiber quality for textiles.

A simple scalp scraping can effectively distinguish fibrosing alopecia from androgenetic alopecia with seborrheic dermatitis.

EFFC might be common but underreported.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

The normalized androgen ratio can help manage conditions with excess androgen activity in women.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The research developed new fortilin protein constructs for potential heart disease treatments.